<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is etiologically linked to endemic Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>), but its contribution to <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">lymphomagenesis</z:e>, versus that of the chromosomal translocation leading to c-myc gene deregulation, remains unclear </plain></SENT>
<SENT sid="1" pm="."><plain>The virus's growth-transforming (Latency III) program of gene expression is extinguished in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells, and only a single <z:mp ids='MP_0001799'>viral</z:mp> protein, the EBV nuclear antigen (EBNA)1, is expressed via the alternative Latency I program </plain></SENT>
<SENT sid="2" pm="."><plain>It is not known if <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> arises from a B-cell subset in which EBV naturally adopts a Latency I <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or if a clone with limited antigen expression has been selected from an EBV-transformed Latency III progenitor pool </plain></SENT>
<SENT sid="3" pm="."><plain>Here we identify a subset of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> in which the Latency III-associated EBNA promoter Wp is active and most EBNAs are expressed, but where a gene deletion has specifically abrogated the expression of EBNA2 </plain></SENT>
<SENT sid="4" pm="."><plain>This implies that <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> can be selected from a Latency III progenitor and that the principal selection pressure is for downregulation of the c-Myc <z:chebi fb="68" ids="48706">antagonist</z:chebi> EBNA2 </plain></SENT>
</text></document>